Search Results - "Nayyereh, Ayati"

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran by Hashemi-Meshkini, Amir, Tajik, Amirmohammad, Ayati, Nayyereh, Nikfar, Shekoufeh, Koochak, Reza, Yaghoubifard, Saeed, Abbasi, Azam, Varmaghani, Mehdi

“…BackgroundThe present study aimed to determine the cost-effectiveness of ticagrelor compared with clopidogrel in Iranian patients with acute coronary syndrome…”
Get full text

Comparison of Treatment Response Achieved by Tablet Splitting Versus Whole Tablet Administration of Levothyroxine in Patients with Thyroid Cancer by Ashrafpour Ramin, ayati Narjess, Sadeghi Ramin, Zare, Namdar Samira, Nayyereh, Ayati, Ghahremani Somayyeh, Zakavi, Seyed Rasoul

“…Objective(s):TSH suppression by Levothyroxine consumption is a mainstay of thyroid cancer treatment. Tablet-splitting is a worldwide approach in dose…”
Get full text

Short and long term impacts of COVID-19 on the pharmaceutical sector by Ayati, Nayyereh, Saiyarsarai, Parisa, Nikfar, Shekoufeh

“…Background The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. This pandemic had major effects…”
Get full text

Cost-effectiveness of Empagliflozin Compared to Liraglutide in Iran Based on Cardiovascular Outcome Trials in Type 2 Diabetes Mellitus by Nayyereh Ayati, Somayeh Layeghi-Ghalehsoukhteh, Alireza Esteghamati

“…Background: Empagliflozin and liraglutide are anti-hyperglycemic agents with proven cardiovascular benefits in Type 2 Diabetes Mellitus (T2DM) patients with…”
Get full text

The Cost-Effectiveness Analysis of Ozanimod in Comparison to Fingolimod in Iran by Ayati, Nayyereh, Faraji, Hoda, Dezfoliyan, Sepideh, Sahraian, Mohammad Ali

“…Ozanimod is a sphingosine-1-phosphate receptor modulator, which acts as a relapsing-remitting multiple sclerosis (RRMS) disease modifying therapy. The…”
Get full text

Production and regulatory issues for theranostics by Giammarile, Francesco, Paez, Diana, Zimmermann, Richard, Cutler, Cathy S, Jalilian, Amirreza, Korde, Aruna, Knoll, Peter, Ayati, Nayyereh, Lewis, Jason S, Lapi, Suzanne E, Delgado Bolton, Roberto C, Kunikowska, Jolanta, Estrada Lobato, Enrique, Urbain, Jean-Luc, Holmberg, Ola, Abdel-Wahab, May, Scott, Andrew M

“…Theranostics has become a major area of innovation and progress in cancer care over the last decade. In view of the introduction of approved therapeutics in…”
Get full text

Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis by Ayati, Nayyereh, Taheri, Saeed, Sahraian, Mohammad Ali, Nikfar, Shekoufeh

“…Background: The current study desired to conduct an economic analysis on ocrelizumab (OCR), a new relapsing multiple sclerosis (RMS) treatment strategy, in…”
Get full text

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics by Scott, Andrew M, Zeglis, Brian M, Lapi, Suzanne E, Scott, Peter J H, Windhorst, Albert D, Abdel-Wahab, May, Giammarile, Francesco, Paez, Diana, Jalilian, Amirreza, Knoll, Peter, Korde, Aruna, Vichare, Shrikant, Ayati, Nayyereh, Lee, Sze Ting, Lyashchenko, Serge K, Zhang, Jingjing, Urbain, Jean Luc, Lewis, Jason S

“…Although the promise of radionuclides for the diagnosis and treatment of disease was recognised soon after the discovery of radioactivity in the late 19th…”
Get full text

Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country by Ayati, Nayyereh, Afzali, Monireh, Hasanzad, Mandana, Kebriaeezadeh, Abbas, Rajabzadeh, Ali, Nikfar, Shekoufeh

“…Having multiple dimensions, uncertainties and several stakeholders, the costly pharmacogenomics (PGx) is associated with dynamic implementation complexities…”
Get full text

Radiotherapy and theranostics: a Lancet Oncology Commission by Abdel-Wahab, May, Giammarile, Francesco, Carrara, Mauro, Paez, Diana, Hricak, Hedvig, Ayati, Nayyereh, Li, Jing Jing, Mueller, Malina, Aggarwal, Ajay, Al-Ibraheem, Akram, Alkhatib, Sondos, Atun, Rifat, Bello, Abubakar, Berger, Daniel, Delgado Bolton, Roberto C, Buatti, John M, Burt, Graeme, Bjelac, Olivera Ciraj, Cordero-Mendez, Lisbeth, Dosanjh, Manjit, Eichler, Thomas, Fidarova, Elena, Gondhowiardjo, Soehartati, Gospodarowicz, Mary, Grover, Surbhi, Hande, Varsha, Harsdorf-Enderndorf, Ekaterina, Herrmann, Ken, Hofman, Michael S, Holmberg, Ola, Jaffray, David, Knoll, Peter, Kunikowska, Jolanta, Lewis, Jason S, Lievens, Yolande, Mikhail-Lette, Miriam, Ostwald, Dennis, Palta, Jatinder R, Peristeris, Platon, Rosa, Arthur A, Salem, Soha Ahmed, dos Santos, Marcos A, Sathekge, Mike M, Shrivastava, Shyam Kishore, Titovich, Egor, Urbain, Jean-Luc, Vanderpuye, Verna, Wahl, Richard L, Yu, Jennifer S, Zaghloul, Mohamed Saad, Zhu, Hongcheng, Scott, Andrew M

“…Following on from the 2015 Lancet Oncology Commission on expanding global access to radiotherapy, Radiotherapy and theranostics: a Lancet Oncology Commission…”
Get full text

A Systematic Review and Economic Evaluation of Sumatriptan Nasal Spray Versus its Oral Tablet by Golnoosh Alipour Haris, Nayyereh Ayati, Ali Mehramizi, Peivand Ghasemzadeh, Mahshid Arabi, Shekoufeh Nikfar

“…Background: Sumatriptan is one of the leading medicines in migraine treatment. This study aimed to evaluate the cost-effectiveness (in the context of Iran) of…”
Get full text

Cladribine tablets are a cost-effective strategy in high-disease activity relapsing multiple sclerosis patients in Iran by Ayati, Nayyereh, Fleifel, Lora, Sahraian, Mohammad Ali, Nikfar, Shekoufeh

“…Background: Cladribine tablets are the foremost oral immune-reconstitution therapy for high disease activity relapsing multiple sclerosis (HDA-RMS). We aimed…”
Get full text

Cladribine Tablets Are a Cost-Effective and Cost-Saving Treatment Strategy for High Disease Activity Relapsing Multiple Sclerosis Patients in Iran by Ayati, Nayyereh, Fleifel, Lora, Sharifi, Shahdak, Sahraian, Mohammad Ali, Nikfar, Shekoufeh

Get full text

A cost minimization analysis of Azelastine/Fluticasone combination nasal spray versus Azelastine and Fluticasone nasal sprays monotherapy in moderate to severe allergic rhinitis in Iran by Nayyereh Ayati, Delara Babaie, Shekoufeh Nikfar, Erfan Rohani, Marzieh Nosrati, Pardis Zaboli

“…Background: Allergic Rhinitis (AR) is a symptomatic disorder which is due to allergen exposure and IgE inflammatory pathway activation in respiratory tract…”
Get full text

Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors by Ghayour-Mobarhan, Majid, Ayati, Nayyereh, Sahebkar, Amirhossein, Moohebati, Mohsen, Ayati, Narjes, Elyasi, Sepideh, Mohammadpour, Amir Houshang

“…Previous studies have shown that Asymmetric Dimethyl Arginine (ADMA) is increased significantly during coronary artery diseases (CAD). However it is not clear…”
Get full text